2. Anthropomorphic test devices (ATDs) and human body models (HBMs)

Every HBM injury metric ultimately traces back to a measurement source. That source is either a physical anthropomorphic test device (ATD) instrumented with transducers, or a computational human body model (HBM) solved inside a finite element or multibody environment. The two are not interchangeable, and treating them as such is one of the most common sources of misinterpretation in occupant safety work. This section establishes what each tool actually measures, where each is trustworthy, and how their limitations propagate into the tissue risk numbers you will interpret throughout the rest of the course.

What an ATD physically is, and what it can report

A crash test dummy is a mechanical surrogate built to approximate the mass distribution, joint stiffness, and external geometry of a human occupant at a defined percentile. A Hybrid III 50th percentile male, for example, carries accelerometers in the head, chest, and pelvis, a six-axis upper-neck load cell, chest deflection potentiometers, and femur and tibia load cells. The dummy does not measure tissue stress. It measures rigid-body kinematics and reaction loads at a small number of discrete interfaces, and those signals are then converted into injury criteria through empirically derived transfer functions.

This distinction matters operationally. When a Hybrid III reports a chest deflection of 63 mm, the number is a piston displacement inside the rib cage analog, not a strain field in myocardial tissue. The associated criterion — for example a maximum chest deflection threshold normalized by torso depth — was regressed against cadaver and animal data decades ago. The ATD is therefore a calibrated proxy: repeatable, legally standardized, and comparable across labs, but structurally incapable of resolving local injury.

ATD strengths are real and should not be dismissed. They offer high run-to-run repeatability (typically within a few percent for a given lab and sled configuration), traceable calibration per SAE J211 filtering and channel class, and a regulatory pedigree — FMVSS 208, ECE R94/R95, and Euro NCAP all define pass/fail in ATD terms. If your question is "does this restraint configuration meet the regulatory envelope," the ATD is the correct and often the only admissible instrument.

What an HBM computes, and why it is a different kind of object

A human body model is a discretized representation of anatomy — cortical and trabecular bone, ligaments, cartilage, solid organs, vasculature in some models — solved with explicit time integration. A whole-body FE HBM such as the GHBMC 50th percentile male occupies roughly 2 million elements; regional models of the head or thorax are far denser. Because the model resolves geometry and material behavior, it can output quantities the ATD cannot: maximum principal strain in the corpus callosum, first principal strain in cortical bone, von Mises stress in the liver capsule, or axonal strain rate in brainstem white matter.

The cost of that resolution is a chain of assumptions. Material properties for soft tissue are frequently derived from low-rate or ex vivo tests and extrapolated to high strain rates. Boundary conditions between organs are simplified. The model's mesh density determines the spatial frequency of strain it can represent — a 5 mm element cannot resolve a 2 mm sulcus. And the injury threshold applied to the output (say, 0.21 first principal strain for cortical bone) carries its own uncertainty from the PMHS dataset it was regressed from. An HBM does not deliver truth; it delivers a mechanistically structured estimate whose credibility depends entirely on validation against the loading regime you are actually simulating.

Do not compare an ATD-derived criterion value and an HBM-derived tissue metric as if they share a scale. A Hybrid III chest deflection of 63 mm and an HBM myocardial strain of 0.18 are not two measurements of the same quantity. They are outputs of different models with different validation bases, and only the associated risk curves make them loosely comparable — and then only within their respective applicability domains.

Matching the tool to the loading regime

The decisive question is not "which is more accurate" but "which has been validated for this loading direction, rate, and boundary condition." An HBM validated against frontal PMHS sled tests at 40 km/h may perform poorly in a lateral far-side impact with a deploying side airbag, because the validation matrix never covered that path. Similarly, an ATD's biofidelity ranking is direction-dependent: the Hybrid III is well correlated in frontal chest loading and comparatively poor in lateral shoulder and pelvic loading, which is precisely why side-impact dummies (ES-2re, WorldSID) exist as separate devices with their own corridors.

A practical screening rule used in many occupant safety groups: if the loading path lies inside the tool's published validation matrix and the question is regulatory or comparative, use the ATD; if the question concerns a body region, a local injury mechanism, or a design space outside the ATD's calibrated range, use the HBM — and then explicitly document which validation cases bracket your load case. Where both are available, run them in parallel and treat divergence as a signal to investigate, not as noise to average away.

ATD and HBM measurement chains and their convergence into tissue risk assessment Two parallel measurement chains: an ATD chain producing transducer signals converted by empirical criteria, and an HBM chain producing solved tissue fields converted by tissue thresholds. Both feed a risk assessment stage that must reconcile their differing validation domains. ATD chain — physical surrogate Instrumented dummy (Hybrid III / WorldSID) head & chest accelerometers, neck & femur load cells, chest potentiometer Transducer signals → SAE J211 filtering rigid-body kinematics and interface reaction loads Empirical injury criteria HIC, Nij, chest deflection, femur force, BrIC HBM chain — computational anatomy Whole-body FE model (GHBMC-class, ~2M elements) bone, ligament, solid organ, vasculature material models Explicit solve → tissue field output principal strain, strain rate, von Mises stress per element Tissue-level thresholds cortical bone strain, axonal strain, organ capsule stress Reconciliation against validation domain loading direction · rate · boundary condition · published corridor coverage Tissue risk assessment with stated confidence ATD limitation no local tissue state; criteria regressed on legacy PMHS data HBM limitation material extrapolation; mesh-limited resolution; narrow validation matrix

Worked example: reading the same event through both tools

Consider a frontal sled case at 40 km/h with a three-point belt and a 50th percentile male occupant. The ATD run yields a chest deflection of 58 mm and a resultant chest acceleration of 42 g. Applying the deflection-based criterion with a torso-depth normalization of 229 mm gives a normalized deflection of 0.253; against a commonly cited 63 mm reference threshold, the ATD indicates a chest injury risk in the moderate range. The HBM run of the same sled pulse, with the belt routed identically, reports a peak first principal strain of 0.14 in the right fourth rib cortical shell and 0.09 in the myocardium.

These two results are consistent in direction but not in kind. The ATD number is a single scalar with a population-level risk curve attached. The HBM number is a spatial field with a location attached — it tells you the load concentrates on the right anterior rib arc, which is exactly the kind of information you need to redesign a belt anchor or a load limiter. What the HBM cannot tell you is whether 0.14 is a validated threshold for this specific belt geometry, because the model's rib validation cases may have used a different anchor position and a different pretensioner profile. The correct interpretation is: the ATD confirms the case sits in a known risk band; the HBM localizes the mechanism; neither alone justifies a design decision.

When reporting either result, always state the tool, its version or calibration date, the validation cases that bracket the load case, and the filter class applied. A chest deflection number without its channel filter and normalization basis is not reproducible, and an HBM strain value without its element size and material card version is not auditable.

Where the two tools genuinely diverge

Divergence is most informative at the edges of the validation envelope. In lateral loading, an ATD's shoulder deflection is governed by a mechanical linkage that was tuned to match a specific corridor; an HBM's lateral chest response depends on rib curvature, cortical thickness distribution, and intercostal stiffness, each with its own uncertainty. If the ATD passes and the HBM predicts high rib strain, the likely explanations are a boundary-condition mismatch (belt or airbag contact patch), a material card that is too stiff at high rate, or a genuine mechanism the ATD cannot see. The diagnostic move is to compare the two against a shared intermediate quantity — chest compression versus time, or the contact force at the shoulder — before concluding which tool is wrong.

The practical takeaway for metric interpretation is that every number you will read in later chapters carries a provenance tag. An ATD-derived criterion is a population-referenced scalar with strong repeatability and weak spatial resolution. An HBM-derived tissue metric is a spatially resolved estimate with strong mechanistic content and validation-dependent credibility. Tissue risk assessment is the act of combining them honestly — using the ATD to anchor the case in a known regulatory and statistical frame, and using the HBM to explain where and why the tissue is loaded — while stating clearly which parts of the conclusion rest on validated ground and which are extrapolation.

← Previous 📖 Contents Next →